[Research Advancement on EGFR Mutation Detection of Cell-free DNA and Tumor Cell in Peripheral Blood of Patients with Non-small Cell Lung Cancer].

about

[Research Advancement on EGFR Mutation Detection of Cell-free DNA and Tumor Cell in Peripheral Blood of Patients with Non-small Cell Lung Cancer].

Item

http://www.wikidata.org/entity/Q51057061

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

[Research Advancement on EGFR ...... h Non-small Cell Lung Cancer].

@en

[Research Advancement on EGFR ...... h Non-small Cell Lung Cancer].

@nl

type

Item

label

[Research Advancement on EGFR ...... h Non-small Cell Lung Cancer].

@en

[Research Advancement on EGFR ...... h Non-small Cell Lung Cancer].

@nl

prefLabel

[Research Advancement on EGFR ...... h Non-small Cell Lung Cancer].

@en

[Research Advancement on EGFR ...... h Non-small Cell Lung Cancer].

@nl

P1476

[Research Advancement on EGFR ...... h Non-small Cell Lung Cancer].

@en

P2093

Mengzhao Wang

http://www.w3.org/2001/XMLSchema#string

Yan Xu

http://www.w3.org/2001/XMLSchema#string

Yu Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.

Global cancer statistics, 2012

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

High-throughput droplet digital PCR system for absolute quantitation of DNA copy number

Detection of mutations in EGFR in circulating lung-cancer cells

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

P304

766-772

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3779/J.ISSN.1009-3419.2016.11.08

http://www.w3.org/2001/XMLSchema#string

P407

Chinese

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27866520

http://www.w3.org/2001/XMLSchema#string

P932

5999632

http://www.w3.org/2001/XMLSchema#string